UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Oncogene, ISSN 0950-9232, 02/2019, Volume 38, Issue 7, pp. 950 - 964
Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Receptors, Estrogen - metabolism | Receptors, Estrogen - genetics | Humans | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Neoplasm Proteins - metabolism | Bone Neoplasms - pathology | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Mammary Neoplasms, Animal - pathology | Animals | Breast Neoplasms - genetics | Receptor Activator of Nuclear Factor-kappa B - biosynthesis | Breast Neoplasms - pathology | Mammary Neoplasms, Animal - metabolism | Receptor Activator of Nuclear Factor-kappa B - genetics | Female | Bone Neoplasms - genetics | Mice | Mice, Inbred BALB C | Neoplasm Proteins - genetics | Mammary Neoplasms, Animal - genetics | TOR protein | Phosphorylation | Tumor cells | Invasiveness | Therapeutic applications | Breast cancer | Bone tumors | Metastasis | Kinases | Metastases | Bone growth | Bone cancer | Skeleton | TRANCE protein | Bioinformatics | Tumors | Index Medicus | Breast Neoplasms/pathology | Mammary Neoplasms, Animal/genetics | Genomics | Bone Neoplasms/secondary | Receptors, Estrogen/metabolism | Life Sciences | Mammary Neoplasms, Animal/pathology | Mammary Neoplasms, Animal/metabolism | Receptor Activator of Nuclear Factor-kappa B/genetics | Neoplasm Proteins/genetics | Neoplasm Proteins/metabolism | Receptor Activator of Nuclear Factor-kappa B/biosynthesis | Receptors, Estrogen/genetics | Biochemistry, Molecular Biology | Bone Neoplasms/metabolism | Bone Neoplasms/genetics | Bone Neoplasms/pathology | Breast Neoplasms/genetics | Breast Neoplasms/metabolism | Cancer
Journal Article
Nature cell biology, ISSN 1465-7392, 08/2018, Volume 20, Issue 8, pp. 954 - 965
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Osteosarcoma - drug therapy | Mad2 Proteins - metabolism | Humans | Multiprotein Complexes | Ovarian Neoplasms - pathology | Bone Neoplasms - pathology | DNA Breaks, Double-Stranded | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Telomere-Binding Proteins - genetics | DNA End-Joining Repair | HEK293 Cells | Female | Bone Neoplasms - genetics | Ovarian Neoplasms - metabolism | Bone Neoplasms - drug therapy | BRCA1 Protein - deficiency | Telomere-Binding Proteins - metabolism | Ovarian Neoplasms - drug therapy | Osteosarcoma - metabolism | DNA-Binding Proteins | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinational DNA Repair | Tumor Suppressor p53-Binding Protein 1 - genetics | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Proteins - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Proteins - metabolism | Breast Neoplasms - pathology | Mad2 Proteins - genetics | Cell Line, Tumor | Mice | Osteosarcoma - genetics | Cell Cycle Proteins | Osteosarcoma - pathology | Care and treatment | DNA | Cancer cells | Breast cancer | Genetic aspects | Research | Gene expression | Single-stranded DNA | DNA damage | Homologous recombination | Poly(ADP-ribose) | Homology | Genomes | Inactivation | Proteins | Ribose | Null cells | Deoxyribonucleic acid--DNA | BRCA2 protein | CRISPR | Deactivation | BRCA1 protein | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Oligosaccharides | Double-strand break repair | Screens | Cisplatin | Inhibitors | Prostate | Viability | Tumors | Index Medicus | Telomere-Binding Proteins / metabolism | Osteosarcoma / genetics | Telomere-Binding Proteins / genetics | BRCA1 Protein / genetics | Cellular Biology | Genetics | Proteins / genetics | Osteosarcoma / drug therapy | Ovarian Neoplasms / genetics | Mad2 Proteins / genetics | Proteins / metabolism | Breast Neoplasms / drug therapy | Breast Neoplasms / metabolism | Tumor Suppressor p53-Binding Protein 1 / genetics | BRCA1 Protein / deficiency | Ovarian Neoplasms / metabolism | Mad2 Proteins / metabolism | Breast Neoplasms / pathology | Bone Neoplasms / genetics | Ovarian Neoplasms / pathology | Bone Neoplasms / pathology | Life Sciences | Bone Neoplasms / drug therapy | Ovarian Neoplasms / drug therapy | Osteosarcoma / metabolism | Biochemistry, Molecular Biology | Breast Neoplasms / genetics | Drug Resistance, Neoplasm / genetics | Osteosarcoma / pathology | Bone Neoplasms / metabolism | Poly(ADP-ribose) Polymerase Inhibitors / pharmacology | Cisplatin / pharmacology | Molecular biology | Tumor Suppressor p53-Binding Protein 1 / metabolism | Cancer
Journal Article
Head & neck, ISSN 1043-3074, 12/2016, Volume 38, Issue 12, pp. 1847 - 1854
sinonasal cavities | metastases | maxillary sinus | paranasal sinuses | nasal cavity | Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Bone Neoplasms - mortality | Prognosis | Bone Neoplasms - therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - pathology | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Bone Neoplasms - pathology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Thyroid Neoplasms - therapy | Nasal Cavity - pathology | Female | Liver Neoplasms - pathology | Kidney Neoplasms - therapy | Paranasal Sinus Neoplasms - therapy | Prostatic Neoplasms - pathology | Thyroid Neoplasms - mortality | Risk Assessment | Carcinoma, Renal Cell - pathology | Lung Neoplasms - therapy | Kidney Neoplasms - mortality | Maxillary Sinus Neoplasms - mortality | Prostatic Neoplasms - mortality | Paranasal Sinus Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Breast Neoplasms - pathology | Survival Analysis | Carcinoma, Renal Cell - therapy | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Paranasal Sinus Neoplasms - secondary | Maxillary Sinus Neoplasms - therapy | Maxillary Sinus Neoplasms - secondary | Thyroid Neoplasms - pathology | Radiotherapy | Metastasis | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 6, pp. 976 - 983
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Feasibility Studies | Young Adult | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Soft Tissue Neoplasms - secondary | Deoxycytidine - administration & dosage | Liver Neoplasms - drug therapy | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | International Agencies | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab | Index Medicus | Liver Neoplasms | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Fluorouracil | Antineoplastic Combined Chemotherapy Protocols | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Deoxycytidine | Soft Tissue Neoplasms
Journal Article
European urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 270 - 273
Urology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Bone Neoplasms - mortality | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Bone Neoplasms - secondary | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Prostatic Neoplasms, Castration-Resistant - pathology | Liver Neoplasms - blood | Lung Neoplasms - secondary | Time Factors | Kallikreins - blood | Bone Neoplasms - drug therapy | Bone Neoplasms - blood | Liver Neoplasms - secondary | Bone Neoplasms - diagnostic imaging | Prostatic Neoplasms, Castration-Resistant - blood | Risk Factors | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Liver Neoplasms - diagnostic imaging | Prostate-Specific Antigen - blood | Phenotype | Lung Neoplasms - diagnostic imaging | Lung Neoplasms - blood | Prostatic Neoplasms, Castration-Resistant - mortality | Prostatic Neoplasms, Castration-Resistant - diagnostic imaging | Liver cancer | Prostate cancer | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 08/2006, Volume 91, Issue 8, pp. 2892 - 2899
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Vertebrates: endocrinology | Malignant tumors | Thyroid. Thyroid axis (diseases) | Biological and medical sciences | Endocrinopathies | Medical sciences | Prognosis | Adenocarcinoma, Follicular - radiotherapy | Adenocarcinoma, Follicular - pathology | Humans | Middle Aged | Bone Neoplasms - secondary | Child, Preschool | Lung Neoplasms - radiotherapy | Male | Carcinoma, Papillary - secondary | Iodine Radioisotopes - therapeutic use | Lung Neoplasms - secondary | Adenocarcinoma, Follicular - secondary | Adult | Female | Child | Thyroid Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Survival Rate | Treatment Outcome | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - pathology | Bone Neoplasms - radiotherapy | Carcinoma, Papillary - radiotherapy | Adolescent | Aged | Thyroid Neoplasms - pathology | Index Medicus | Abridged Index Medicus | Thyroid Neoplasms | Iodine Radioisotopes | Lung Neoplasms | Bone Neoplasms | Life Sciences | Neoplasm Metastasis | Adenocarcinoma, Follicular | Carcinoma, Papillary | Santé publique et épidémiologie
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis | Index Medicus
Journal Article